Michael Korn, MD

Articles by Michael Korn, MD

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic

ByUte Klaassen, MD,Hans Jochen Wilke, MD,Christian Müller, MD,David Borquez, MD,Michael Korn, MD,Klaus Diergarten, MD,Siegfried Seeber, MD, PhD

April 1st 1997

Our phase II study results demonstrating high efficacy and low toxicity for a weekly schedule of high-dose, 24-hour infusional 5-fluorouracil(5-FU)/folinic acid (HD5-FU/FA) in intensively pretreated patients with metastatic

Latest Updated Articles

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic
Published: April 1st 1997 | Updated:

Michael Korn, MD

Articles by Michael Korn, MD

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic

Latest Updated Articles

Trending on CancerNetwork

How Supportive Care Methods Can Improve Oncology Outcomes

AQUILA Shows “Striking” Benefits With Daratumumab in Smoldering Myeloma

FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas

Chlorotoxin-Based Therapy Shows Safety, Feasibility in Glioblastoma

Pembrolizumab Regimen May Show Synergy in Melanoma Populations